Stability of blood phenylalanine levels and IQ in children with phenylketonuria.

Stability of blood phenylalanine levels and IQ in children with phenylketonuria. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Stability of blood phenylalanine levels and IQ in children with phenylketonuria. Abstract Text:

Variability of metabolic control in phenylketonuria (PKU) potentially affects cognitive outcome in early and continuously treated children with this condition. The possibility that homeostasis is more important than the absolute level of exposure to phenylalanine (phe) has not previously been examined. A meta-analysis of 40 studies showed that in children with phenylketonuria (PKU), mean lifetime blood phe levels were significantly correlated with Full Scale IQ (FSIQ) (r=-0.34). A similar correlation (r=-0.35) was found between FSIQ and mean exposure during 0-12 years of age. Most of the studies in the meta-analysis, however, included children who had discontinued the phe restricted diet. None examined the impact of fluctuations in metabolic control in continuously treated children. This is important because new therapies may increase stability in blood phe levels. The question has arisen whether these therapies are beneficial in children whose blood phe levels are generally within the recommended range of 120-360mumol/L. In this study, we describe the relationship between FSIQ and two parameters of metabolic control: (1) mean blood phe level of all reported specimens for each subject, and (2) variability of the blood phe level as indicated by the standard deviation of blood phe levels for each subject. Analyses were performed using lifetime phe levels and levels during three periods (0-6 years, 0-10 years, and >10 years of age). The most recent FSIQ for each child was used in the correlation analyses. Data were collected from medical records on all 46 children born between 1999 and 2006 with early and continuously treated PKU followed at the Metabolism Program at Children's Hospital Boston. The mean age of the children at the time of their most recent FSIQ test was 7.5+3.3 (2.9-15.5) and their mean FSIQ was 104+15 (68-143). The mean lifetime blood phe level in these children was 312+132mumol/L (125-852). The standard deviation of blood phe levels was 182+72mumol/L (96-336). The correlation between lifetime blood phe levels and most recent FSIQ was -.17 (p=0.38) and the correlation between standard deviation of blood phe levels and most recent FSIQ was -.36 (p=.058), not reaching significance, but indicating a trend. These results indicate that stability of blood phe levels may be more important to cognitive functioning than overall exposure to phe in early and continuously treated PKU. In treating PKU, attention should be given to variability in blood phe levels as well as maintenance of phe levels within the recommended range.

Stability of blood phenylalanine levels and IQ in children with phenylketonuria. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE: 2008 Sep-Oct

Stability of blood phenylalanine levels and IQ in children with phenylketonuria. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Molecular genetics and metabolism

VOLUME: 95

Page Numbers: 17-20

Journal Abbreviation: Mol. Genet. Metab.

ISSN: 1096-7206

DAY: 13

MONTH: 08

YEAR: 2008

Stability of blood phenylalanine levels and IQ in children with phenylketonuria. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9805456

Stability of blood phenylalanine levels and IQ in children with phenylketonuria. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Stability of blood phenylalanine levels and IQ in children with phenylketonuria. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Stability of blood phenylalanine levels and IQ in children with phenylketonuria.

AFFILIATION: Children's Hospital Boston, Department of genetics, 1 Autumn street, Room 525, Boston, MA 02115, USA.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Mol Genet Metab

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Stability of blood phenylalanine levels and IQ in children with phenylketonuria Related Publications

• Acquired autoimmunity after viral vaccination is caused by molecular mimicry and antigen complimentarity in the presence of an immunologic adjuvant and specific HLA patterns.
• Activity of chloramphenicol against Escherichia coli circulating in the blood and tissues of immunized dogs.
• Alloxan diabetes in mice.
• Expanded newborn screening: information and resources for the family physician.
• PKU in adolescents: rationale and psychosocial factors in diet continuation.
• Parental tolerance of false-positive newborn screening results.
• Stability of blood phenylalanine levels and IQ in children with phenylketonuria.